KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xylem (XYL) Common Equity (2016 - 2025)

Historic Common Equity for Xylem (XYL) over the last 16 years, with Q3 2025 value amounting to $11.2 billion.

  • Xylem's Common Equity rose 583.96% to $11.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 billion, marking a year-over-year increase of 583.96%. This contributed to the annual value of $10.6 billion for FY2024, which is 462.85% up from last year.
  • According to the latest figures from Q3 2025, Xylem's Common Equity is $11.2 billion, which was up 583.96% from $11.1 billion recorded in Q2 2025.
  • In the past 5 years, Xylem's Common Equity registered a high of $11.2 billion during Q3 2025, and its lowest value of $2.9 billion during Q1 2021.
  • Over the past 5 years, Xylem's median Common Equity value was $9.9 billion (recorded in 2023), while the average stood at $7.1 billion.
  • As far as peak fluctuations go, Xylem's Common Equity surged by 386.85% in 2022, and later skyrocketed by 20939.74% in 2023.
  • Quarter analysis of 5 years shows Xylem's Common Equity stood at $3.2 billion in 2021, then grew by 8.59% to $3.5 billion in 2022, then surged by 190.49% to $10.2 billion in 2023, then grew by 4.63% to $10.6 billion in 2024, then rose by 5.37% to $11.2 billion in 2025.
  • Its Common Equity stands at $11.2 billion for Q3 2025, versus $11.1 billion for Q2 2025 and $10.8 billion for Q1 2025.